| H20020252 | 甲氨蝶吟注射液 | methotrexate | Injection | Chemical Drugs | Import Drug Application | 2002-10-24 | 香港凯健药品（中国）有限公司北京代表处 | | Approval Completed-Pending Certificated | 2003-08-15 | view |
| JYHB0900008 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2009-01-15 | 依比威药品有限公司 | Ebewe Pharma Ges MBH Nfg Kg | Certificate Issued | 2009-06-26 | view |
| JYHB2400462 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2024-08-21 | | | | | view |
| B20000173 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Import Drug Application | 2000-01-01 | Faulding Pharmaceuticals (Hong Kong) Ltd. | Faulding Pharmaceuticals (Hong Kong) Ltd | Approval Completed-Pending Certificated | | view |
| JYHB2002576 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2020-12-14 | Pfizer Australia Pty Ltd | Pfizer Australia Pty Ltd | Certificate Issued | 2021-03-05 | view |
| JXHS2300115 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs(5.1) | Import Drug Application | 2023-12-04 | | | | | view |
| JYHB1601448 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2016-10-31 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2017-04-13 | view |
| JYHB2300135 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2023-02-22 | | | | | view |
| JYHZ1300147 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | License Renew | 2013-07-15 | 上海诺华贸易有限公司 | Shanghai Novartis Trading Ltd | Certificate Issued | 2014-12-11 | view |
| JYHB2200316 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2022-06-24 | | | | | view |
| CYHS2403780 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs(4) | Generic Drug | 2024-11-06 | | | | | view |
| J0401290 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2004-07-20 | | | Certificate Issued | 2005-09-20 | view |
| JYHB2101573 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2021-12-09 | | | | | view |
| CYHS2400491 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs(4) | Generic Drug | 2024-02-05 | | Fresenius Kabi (Wuhan) Pharmaceutical Co Ltd | | | view |
| JYHZ1800250 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | License Renew | 2018-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2019-03-21 | view |
| JYHB1400265 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2014-04-09 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2015-04-07 | view |
| JYHB2200472 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2022-08-31 | | | | | view |
| JYHB0800283 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2008-05-09 | Pfizer (Perth) Pty Limited | Pfizer (Perth) Pty Ltd | Certificate Issued | 2008-10-22 | view |
| JYHZ2400185 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | License Renew | 2024-07-11 | | | | | view |
| JYHB2002206 | 甲氨蝶呤注射液 | methotrexate | Injection | Chemical Drugs | Supplementary Application | 2020-11-02 | Pfizer Australia Pty Ltd | Pfizer Australia Pty Ltd | Certificate Issued | 2020-11-30 | view |
